Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Clinical trial NCT05843253 · RECRUITING

Trial details

NCT number: NCT05843253
Sponsor: Nationwide Children's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High Grade Glioma Diffuse Intrinsic Pontine Glioma Anaplastic Astrocytoma Glioblastoma Glioblastoma Multiforme Diffuse Midline Glioma, H3 K27M-Mutant Metastatic Brain Tumor WHO Grade III Glioma WHO Grade IV Glioma Diffuse Hemispheric Glioma, H3 G34-Mutant

Start date: 2024-08-22
Primary completion: 2029-08-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.